Clinical outcome of Escherichia coli bloodstream infection in cancer patients with/without biofilm formation: a single-center retrospective study

References

• SchwaberMJCarmeliYMortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysisJ Antimicrob Chemother200760591392017848376
   PubMed Web of Science ®Google Scholar
• TajbakhshEAhmadiPAbedpour-DehkordiEArbab-SoleimaniNKhamesipourFBiofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in IranAntimicrob Resist Infect Control201651127042294
   PubMed Web of Science ®Google Scholar
• CostertonJWStewartPSGreenbergEPBacterial biofilms: a common cause of persistent infectionsScience199928454181318132210334980
   PubMed Web of Science ®Google Scholar
• CostertonBMicrobial ecology comes of age and joins the general ecology communityProc Natl Acad Sci U S A200410149169831698415572449
   PubMed Web of Science ®Google Scholar
• FuxCACostertonJWStewartPSStoodleyPSurvival strategies of infectious biofilmsTrends Microbiol2005131344015639630
   PubMed Web of Science ®Google Scholar
• MittalSSharmaMChaudharyUBiofilm and multidrug resistance in uropathogenic Escherichia coliPathog Glob Health20151091262925605466
   PubMed Web of Science ®Google Scholar
• TasciniCSozioECorteLThe role of biofilm forming on mortality in patients with candidemia: a study derived from real world dataInfect Dis (Lond)201850321421928988525
   PubMed Web of Science ®Google Scholar
• LiSKonstantinovSRSmitsRPeppelenboschMPBacterial biofilms in colorectal cancer initiation and progressionTrends Mol Med2017231183027986421
   PubMed Web of Science ®Google Scholar
• RajendranRSherryLNileCJBiofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection – Scotland, 2012-2013Clin Microbiol Infect2016221879326432192
   PubMed Web of Science ®Google Scholar
• BoneRCBalkRACerraFBDefinitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care MedicineChest19921016164416551303622
   PubMed Web of Science ®Google Scholar
• BereketWHemalathaKGetenetBUpdate on bacterial nosocomial infectionsEur Rev Med Pharmacol Sci20121681039104422913154
   PubMed Web of Science ®Google Scholar
• Institute CaLSPerformance Standards for Antimicrobial Susceptibility Testing Supplement. Twenty-Second Informational SupplementM100-S22Wayne, PA, USACLSI2012
   Google Scholar
• SharmaJSharmaMRayPDetection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from IndiaIndian J Med Res201013233233620847381
   PubMed Web of Science ®Google Scholar
• LeeSHKimJYLeeSKJinWKangSGLeeKJDiscriminatory detection of extended-spectrum beta-lactamases by restriction fragment length dimorphism-polymerase chain reactionLett Appl Microbiol200031430731211068913
   PubMed Web of Science ®Google Scholar
• EdelsteinMPimkinMPalaginIEdelsteinIStratchounskiLPrevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitalsAntimicrob Agents Chemother200347123724373214638473
   PubMed Web of Science ®Google Scholar
• StepanovicSVukovicDDakicISavicBSvabic-VlahovicMA modified microtiterplate test for quantification of staphylococcal biofilm formationJ Microbiol Methods200040217517910699673
   PubMed Web of Science ®Google Scholar
• ZhangQZhangWLiZBacteraemia due to AmpC β-lactamase-producing Escherichia coli in hospitalized cancer patients: risk factors, antibiotic therapy, and outcomesDiagn Microbiol Infect Dis201788324725128434898
   PubMed Web of Science ®Google Scholar
• ZhangQLiDBaiCClinical prognostic factors for time to positivity in cancer patients with bloodstream infectionsInfection201644558358827084368
   PubMed Web of Science ®Google Scholar
• KiratisinPApisarnthanarakALaesripaCSaifonPMolecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemicAntimicrob Agents Chemother20085282818282418505851
   PubMed Web of Science ®Google Scholar
• EhlersMMVeldsmanCMakgotlhoEPDoveMGHoosenAAKockMMDetection of blaSHV, blaTEM and blaCTX-M antibiotic resistance genes in randomly selected bacterial pathogens from the Steve Biko academic hospitalFEMS Immunol Med Microbiol200956319119619453751
   PubMedGoogle Scholar
• HirakataYMatsudaJMiyazakiYRegional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002)Diagn Microbiol Infect Dis200552432332916165001
   PubMed Web of Science ®Google Scholar
• LivermoreDMCantonRGniadkowskiMCTX-M: changing the face of ESBLs in EuropeJ Antimicrob Chemother200759216517417158117
   PubMed Web of Science ®Google Scholar
• FeizabadiMMDelfaniSRajiNDistribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, IranMicrob Drug Resist2010161495319961397
   PubMed Web of Science ®Google Scholar
• FangHAtakerFHedinGDornbuschKMolecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006J Clin Microbiol200846270771218094139
   PubMed Web of Science ®Google Scholar
• ArpinCQuentinCGrobostFNationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community settingJ Antimicrob Chemother20096361205121419329798
   PubMed Web of Science ®Google Scholar
• MulveyMRBryceEBoydDAmbler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitalsAntimicrob Agents Chemother20044841204121415047521
   PubMed Web of Science ®Google Scholar
• RomeroEDPadillaTPHernándezAHPrevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamasesDiagn Microbiol Infect Dis200759443343717913435
   PubMed Web of Science ®Google Scholar
• SalverdaMLDe VisserJABarlowMNatural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevanceFEMS Microbiol Rev20103461015103620412308
   PubMed Web of Science ®Google Scholar
• DonelliGVuottoCBiofilm-based infections in long-term care facilitiesFuture Microbiol20149217518824571072
   PubMed Web of Science ®Google Scholar
• NeupaneSPantNDKhatiwadaSChaudharyRBanjaraMRCorrelation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, NepalAntimicrob Resist Infect Control20165526885364
   PubMed Web of Science ®Google Scholar
• SubramanianPUmadeviSKumarSStephenSDetermination of correlation between biofilm and extended spectrum β lactamases producers of EnterobacteriaceaeScho Res J2012212
   Google Scholar
• Jolivet-GougeonABonnaure-MalletMBiofilms as a mechanism of bacterial resistanceDrug Discov Today Technol201411495624847653
   PubMedGoogle Scholar
• SchauflerKSemmlerTPickardDJCarriage of extended-spectrum beta-lactamase-plasmids does not reduce fitness but enhances virulence in some strains of pandemic E. coli lineagesFront Microbiol2016733627014251
   PubMed Web of Science ®Google Scholar
• MartínezJASotoSFabregaARelationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremiaJ Clin Microbiol20064441468147416597878
   PubMed Web of Science ®Google Scholar